Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Arimura, K. Aoshiba, T. Tsuji, J. Tamaoki (Tokyo, Ibaraki, Japan). Chronic low-grade systemic inflammation causes DNA damage in the lungs of mice. Eur Respir J 2013; 42: Suppl. 57, 530

Member's Comments

No comment yet.

Related content which might interest you: Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Autoimmune induction of a COPD-like inflammatory phenotype in mice Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Systemic inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Local and systemic inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 Case control study of chronic obstructive pulmonary disease and its progression Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Source: Eur Respir J 2008; 31: 1334-1356 Year: 2008 Comparison of two murine models of acute and chronic hypersensitivity pneumonitis due to pigeon serum exposure Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Impact of chronic bronchial infection on the lungs and beyond Source: Eur Respir Monogr 2013; 60: 46-57 Year: 2013 Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Chronic intermittent hypoxia induces liver injury in mice with diet induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016 The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 The novel compound Sul-121 inhibits inflammation in experimental models of chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice Source: International Congress 2016 – Immune responses in the lung Year: 2016 Increased laminin deposition and expression of TGF-beta in bronchial biopsies of children with chronic obstructive respiratory diseases Source: Annual Congress 2013 –Paediatric bronchology Year: 2013 Different chronic obstructive pulmonary disease phenotypes, systemic inflammation and the risk of falls Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013